Share Facebook Twitter LinkedIn Pinterest Email Reviva reports FDA acceptance of 4-week RECOVER-2 study for its schizophrenia treatment
BlackRock’s Hambro slams mining firms’ ‘reckless’ share buybacks, urges mine investmentOctober 16, 2026
Wells Fargo wins court order to dismiss former CEO’s pay-related case – report (WFC:NYSE)October 16, 2026